/People

Troy Wilson

Founder

Founder at Kura Oncology · Founder at Avidity Biosciences

United States

FoundedAvidity BiosciencesKura Oncology

Find your path to Troy

Sign up to see every warm intro you have to Troy

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Troy. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Troy Wilson co-founded Kura Oncology, Inc. in 2014 and serves as its President, Chief Executive Officer, and Chairman of the Board. He previously co-founded and led Avidity Biosciences, Araxes Pharma, Wellspring Biosciences, Intellikine, and Ambrx, several of which were acquired by companies including Takeda, Johnson & Johnson, and Novartis, and he currently sits on the boards of Atrium Therapeutics, Puma Biotechnology, Cartography Biosciences, Montara Therapeutics, and Cipher Genetics. Wilson holds a J.D. from New York University and a Ph.D. in bioorganic chemistry and B.A. in biophysics from the University of California, Berkeley.

Founder at Kura Oncology

Intro paths

→

In turn, Troy can intro founders to Kura Oncology's investors below.

Co-founders at Kura Oncology

PR
PINGDA RENExecutive Officer
YLYI LIU
YI LIUExecutive Officer
TWTroy Wilson, Ph.D., J.D.
Troy Wilson, Ph.D., J.D.Co-founder; President, Chief Executive Officer and Chairman of the Board
KM
Kevan M. Shokat, Ph.D.Founding team member

Founder at Avidity Biosciences

Intro paths

→

In turn, Troy can intro founders to Avidity Biosciences's investors below.

Co-founders at Avidity Biosciences

TW
Troy Wilson PhD., JDExecutive Officer, Director
PK
P. Kent HawrylukExecutive Officer
ME
Mark E. DavisDirector

Frequently asked questions

Who is Troy Wilson?
Troy Wilson co-founded Kura Oncology, Inc. in 2014 and serves as its President, Chief Executive Officer, and Chairman of the Board. He previously co-founded and led Avidity Biosciences, Araxes Pharma, Wellspring Biosciences, Intellikine, and Ambrx, several of which were acquired by companies including Takeda, Johnson & Johnson, and Novartis, and he currently sits on the boards of Atrium Therapeutics, Puma Biotechnology, Cartography Biosciences, Montara Therapeutics, and Cipher Genetics. Wilson holds a J.D. from New York University and a Ph.D. in bioorganic chemistry and B.A. in biophysics from the University of California, Berkeley.
Where does Troy Wilson work?
Troy Wilson is Founder of Avidity Biosciences and Founder at Kura Oncology.
What companies did Troy Wilson found?
Troy Wilson founded Avidity Biosciences, Kura Oncology.

Founder mafias

About this profile. Compiled from public sources — Kura Oncology's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights